SCHEMBL22169240

SCHEMBL22169240

N#CCC(=O)N(C#N)Cc1ccc(Cl)cc1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.45
▸ HTT P42858 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ NPC1 O15118 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ POLB P06746 1/20 0.39
▸ CNR2 P34972 2/20 0.38
▸ MAPT P10636 1/20 0.38
▸ PTGS2 P35354 1/20 0.36
▸ KCNH2 Q12809 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ NR1D1 P20393 1/20 0.36
▸ PYCR1 P32322 1/20 0.36
▸ BCL2A1 Q16548 1/20 0.35
▸ LSS P48449 1/20 0.35
▸ CNR1 P21554 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6449074 0.72 MCL1 (0.46) ALDH1A1HTTRAB9ANPC1POLB
SCHEMBL710924 0.70 NPC1 (0.44) ALDH1A1RAB9ANPC1L3MBTL1POLB
SCHEMBL4879817 0.70 ALDH1A1 (0.41) ALDH1A1HTTRAB9ANPC1L3MBTL1
SCHEMBL9818809 0.70 DRD4 (0.43) ALDH1A1HTTRAB9ANPC1L3MBTL1
SCHEMBL10628165 0.70 ALDH1A1 (0.40) ALDH1A1HTTRAB9AL3MBTL1POLB
SCHEMBL11405433 0.69 ALDH1A1 (0.61) ALDH1A1HTTRAB9AL3MBTL1POLB
SCHEMBL14999782 0.69 ALDH1A1 (0.47) ALDH1A1HTTRAB9ANPC1L3MBTL1
SCHEMBL8175414 0.68 POLB (0.50) ALDH1A1HTTRAB9ANPC1L3MBTL1
SCHEMBL17967141 0.68 PLAAT3 (0.45) MAPTMEN1KMT2ACNR1
SCHEMBL5289351 0.68 SNCA (0.41) ALDH1A1POLBMAPTPTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10703746-B2 Mutant IDH1 inhibitors useful for treating cancer THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2020-07-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10703746-B2 Mutant IDH1 inhibitors useful for treating cancer IDH1, IDH3B, IDH3A ALDH1A1 417/4885HTT 2335/4885RAB9A 931/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback